Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Sinopharm International Corporation is an active healthcare and pharmaceutical commercial enterprise within the Sinopharm group, focused primarily on international pharmaceutical trade, medical device distribution, overseas healthcare engineering, and foreign-aid medical projects. Unlike a venture-stage biotech, it operates as a diversified international business and services company rather than a drug discovery developer. Its activities span pharmaceutical import/export, medical equipment sales, hospital and healthcare infrastructure projects, and related healthcare services, with business reach reported across a large number of countries and regions. The company is a wholly owned subsidiary of China National Pharmaceutical Group and forms part of one of China’s largest state-owned healthcare conglomerates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Sinopharm International Corporation.